This site is intended for Healthcare professionals only.

Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it


Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it

KAPL to manufacture the drug for domestic use only

The Ministry of Health and Family Welfare has restricted the manufacture of Oxytocin formulations for domestic use to public sector only from 1st July 2018. It has also banned the import of Oxytocin and its formulations.

From 1st July 2018, no private manufacturer will be allowed to manufacture the drug for domestic use. Only Karnataka Antibiotics & Pharmaceuticals Ltd (KAPL), a public sector company, would be manufacturing this drug for domestic use from that date.

The Oxytocin formulations meant for domestic consumption will be supplied by the manufacturer, i.e. KAPL, to the registered hospitals and clinics in public and private sector directly. Oxytocin in any form or name will not be allowed to be sold through retail Chemist.

All the registered hospitals and clinics in public and the private sector in the country are advised to contact KAPL and place their orders with the company as the drug will not be available with retail chemists or any other manufacturer.

The contact details of KAPL are:

Email: instmkt@kaplindia.com

Mob: Dr. Mukesh Kumar: 9880175766; Mr. Santhosh Kumar: 9901611277; Mr. Sunil Kumar Kaimal: 9845231019



Source: Press Release
0 comment(s) on Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted